Sharechat Logo

Sichuan Province Trial Confirms Truscreen Technology

Monday 19th October 2020

Text too small?

• Second phase of national clinical trial in Sichuan Province reported outstanding results

• Conducted by China Obstetrics and Gynaecology Association (COGA) a peak gynaecology body in China.

• Trial conducted across 14 hospitals with 1,243 patients participating

• Both sensitivity and specificity targeting pre-cancerous and cancerous cervical cells performed in aggregate better than other screening methods (see below table)

Truscreen Group Limited (NZX: TRU ) (Truscreen or Company) is pleased to advise results from The China Obstetrics and Gynaecology Association (COGA) ongoing national clinical trial that will screen over 20,000 women in 100 top-tier public hospitals across 10 provinces in China. The COGA evaluation compares the TruScreen technology to Liquid Based Cytology (LBC), and HPV DNA testing (HPV) and targets a nationwide consensus on Truscreen technology application in China as the main outcome of this large-scale trial.

See the link below for more details:

Sichuan Province Trial Confirms Truscreen Technology

Source: Truscreen Group Limited

  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

Synlait Milk Limited published its Annual Report
Infratil announces offer to acquire stake in Australian diagnostic imaging business, Qscan
Kathmandu Holdings Limited announces Annual Report 2020
Genesis Energy announced its FY21 Q1 Performance Report
Vector announces its operational performance for the 3 months
Abano Scheme Meeting Materials
Westpac and Afterpay announce partnership
NWF agrees a new Variable Volume Fixed Price Agreement
Takeovers Panel states no objection to Metlifecare scheme
PEB Announces Executive Team Changes to Support Growth

IRG See IRG research reports